Johnson Matthey to Return £1.4bn to Shareholders After Honeywell Catalyst Technologies Sale

Johnson Matthey’s £1.4bn Shareholder Windfall: What You Need to Know

If you’ve ever wondered what a corporate glow-up looks like, Johnson Matthey (JM) just delivered a masterclass. The 200-year-old materials science giant is making headlines with its decision to return £1.4 billion to shareholders following the sale of its Catalyst Technologies arm to Honeywell. Let’s unpack why this matters – and what it tells us about JM’s next act.

The Honeywell Deal: A Textbook Exit

JM’s Catalyst Technologies business has been snapped up by Honeywell for an enterprise value of £1.8 billion – a juicy 13.3x EBITDA multiple. For context, that’s the kind of valuation that makes even seasoned M&A bankers nod approvingly. Here’s the breakdown:

• £1.6bn net proceeds after costs (with £1.4bn earmarked for shareholders)
• Completion expected by H1 2026, with return mechanism details pending
• Catalyst Technologies contributed £92m underlying operating profit in 2024/25 – but JM sees bigger fish to fry

Strategic Pivot: From Jack-of-All-Trades to Focused Powerhouse

CEO Liam Condon isn’t just selling a business – he’s surgically reshaping JM. The new-look company will laser-focus on:

1. Clean Air Dominance

• Targeting 16-18% operating margins by 2027/28 (up from 11.8%)
• £2bn+ sales expected by 2027/28 (90% already won)
• Betting on ICE longevity as EV adoption slows

2. PGM Services Supremacy

• World’s largest secondary PGM refiner building a £100m state-of-the-art facility
• 30% margins targeted by 2027/28 despite current refinery transition costs

As Condon put it: “We’re creating a leaner JM built for sustainable cash generation.” Translation? This isn’t a retreat – it’s a strategic concentration of firepower.

Financial Snapshot: Resilience Meets Restructuring

Against a backdrop of automotive sector headwinds and hydrogen market growing pains, JM delivered:

• 6% growth in underlying operating profit (constant currency)
• £521m free cash flow (up from £189m)
• Dividend maintained at 77p/share despite £329m in impairment charges

The elephant in the room? A £134m impairment in Hydrogen Technologies. While JM remains committed to this space, the reality check here is stark – the green hydrogen market is moving slower than a London bus at rush hour.

Looking Ahead: The Cash Machine Blueprint

JM’s playbook for 2027/28 reads like a value investor’s wishlist:

• £250m+ annual sustainable free cash flow
• Net debt/EBITDA target slashed to 1.0-1.5x (from 1.5-2.0x)
• Shareholder returns growing to £200m+/year from 2026/27

Key to this will be £500m cumulative capex through 2027/28 – mostly tied up in that shiny new PGM refinery. Once complete, JM expects working capital improvements worth £250m.

Risks & Watch Points

No transformation is without its hurdles:

• Tariff tango: JM’s global footprint helps, but trade wars remain a wildcard
• PGM price exposure: Every $100/oz move in palladium = ~£1m profit impact
• Hydrogen hope: Breakeven target by 2025/26 looks ambitious given market delays

The Bottom Line

JM is executing the corporate equivalent of a triathlete shedding excess weight before race day. By jettisoning Catalyst Technologies at a premium valuation and doubling down on cash-generative core businesses, they’re positioning for what Condon calls “a new era of value creation”.

For shareholders, the £1.4bn return is just the opening act. The real show will be whether this streamlined JM can deliver on its promise of becoming a cash flow machine while navigating the energy transition’s bumpy road. One to watch – with dividends in hand.